Judit Anido Folgueira
Founder at Mosaic Biomedicals SL
Network origin in Judit Anido Folgueira first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada.
11
| Subsidiary | Hospital/Nursing Management | 11 |
Mosaic Biomedicals SL
 Mosaic Biomedicals SL Hospital/Nursing ManagementHealth Services Mosaic Biomedicals SL develops personalized cancer treatments. It is engaged in the realization and development of scientific and technical research projects in the field of oncological and tumor diseases. The company was founded by Joan Seoane, Judit Anido Folgueira and José Baselga on April 19, 2013 and is headquartered in Barcelona, Spain.
5
| Subsidiary | Hospital/Nursing Management | 5 |
Asabys Partners SGEIC SA
 Asabys Partners SGEIC SA Investment ManagersFinance Asabys Partners SGEIC SA (Asabys Partners) is an independent venture capital firm founded in 2019 by Clara Campàs-Moya and Josep Lluís Sanfeliu Benet. The firm is headquartered in Barcelona, Spain.
4
| Private Company | Investment Managers | 4 |
Nuage Therapeutics SL
 Nuage Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Nuage Therapeutics SL is a biotech company located in Barcelona, ES. The company's address is Parc Científic de Barcelona C/ Baldiri Reixac 4-8 (Torre D) 08028 Barcelona. The company also has a chief financial officer who holds a PhD in biology from the University of Barcelona and an MBA from Duke University. Nuage Therapeutics specializes in careers for data scientists, lab technicians in protein purification and cell biology. The Spanish company's founders include Xavier Salvatella, an ICREA professor and leader of the Laboratory of Molecular Biophysics at IRB Barcelona, and Mateusz Besiaga, a PhD student and MSCA fellow in the Laboratory of Molecular Biophysics at IRB Barcelona. The company's team includes experts in transcriptional control, nuclear condensates, genome structure, genetics, developmental biology, and biomedical research. The company was founded in 2021, and Judit Anido Folgueira has been the CEO of the company since 2022.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Judit Anido Folgueira via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
I5 Surviving Corp.
 I5 Surviving Corp. Medical/Nursing ServicesHealth Services Inception 5, Inc. develops and researches novel small molecule demyelinating therapies for patients with multiple sclerosis. The company is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Salford | College/University | Undergraduate Degree | |
| McGill University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of Toronto | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Chairman Private Equity Investor Private Equity Investor | |
Banyan Biomarkers, Inc.
 Banyan Biomarkers, Inc. Medical/Nursing ServicesHealth Services Banyan Biomarkers, Inc. engages in the commercialization of vitro diagnostic tests for the detection of brain injury and neurological diseases. It develops blood test to accurately and quickly diagnose traumatic brain injury. The company was founded by Nancy Denslow, Ronald L. Hayes, and Kevin Wang in 2002 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
| T2 BIOSYSTEMS, INC. | Medical Specialties | Director of Finance/CFO Private Equity Investor | |
Compagnie Merieux Alliance SAS
 Compagnie Merieux Alliance SAS Investment Trusts/Mutual FundsMiscellaneous Compagnie Mérieux Alliance SAS owns shares and interests in firms that manufactures, sells, and distributes medicines and other pharmaceutical products. The company is headquartered in Lyon, France. | Investment Trusts/Mutual Funds | Private Equity Investor | |
| Versant EuroVentures | Chairman Chief Executive Officer | ||
Tornado Spectral Systems, Inc.
 Tornado Spectral Systems, Inc. Medical SpecialtiesHealth Technology Tornado Spectral Systems, Inc. develops real-time optical process analyzers and imaging solutions. Its optical solutions include HyperFlux PRO Plus, HyperFlux PRO and HyperFlux U1. The firm offers its services to pharmaceuticals, oil and gas, bio processing, specialty chemical, plastics and polymers industries. The company was founded by Jae Kim and Arsen R. Hajian in 2010 and is headquartered in Toronto, Canada. | Medical Specialties | Private Equity Investor | |
Company Builders LLC
 Company Builders LLC Miscellaneous Commercial ServicesCommercial Services Company Builders LLC provides business development consulting services. The private company is based in Albuquerque, NM. The CEO of the company is Paul Andrew Ruppanner. | Miscellaneous Commercial Services | Chairman | |
MeMed Diagnostics Ltd.
 MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | Medical Specialties | Consultant / Advisor | |
Qvella Corp.
 Qvella Corp. Medical SpecialtiesHealth Technology Qvella Corp provides molecular diagnostics. It develops a differentiated technology for pathogen detection by direct sampling of boldily fluids without the need for culturing or time consuming sample processing. The company was founded by Tino Alavie in 2009 and is headquartered in Richmond Hill, Canada. | Medical Specialties | Director/Board Member | |
Blueline Bioscience
 Blueline Bioscience Investment ManagersFinance Blueline Bioscience acts as an alternative investment manager. The company is headquartered in Toronto, Canada. | Investment Managers | Director/Board Member Director/Board Member Director/Board Member | |
Turnstone Biologics, Inc.
 Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Inception IBD, Inc.
 Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Versant Ventures VI GP-GP LLC | Corporate Officer/Principal | ||
Versant Venture Capital VI (Canada) LP
 Versant Venture Capital VI (Canada) LP Investment ManagersFinance Versant Venture Capital VI (Canada) LP operates as a pooled investment fund. The company is headquartered in San Francisco, CA. | Investment Managers | Director/Board Member Director/Board Member | |
BlueRock Therapeutics Canada ULC
 BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
| Versant Ventures Canada Ltd. | Investment Managers | Private Equity Investor | |
| REPARE THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
| Versant Ventures VII GP-GP LLC | Corporate Officer/Principal | ||
| TURNSTONE BIOLOGICS CORP. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Northern Mosaic LP
 Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Chinook Therapeutics U.S., Inc.
 Chinook Therapeutics U.S., Inc. Information Technology ServicesTechnology Services Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA. | Information Technology Services | Director/Board Member | |
Ventus Therapeutics, Inc.
 Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman | |
Ventus Therapeutics U.S., Inc.
 Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Medical Distributors | Chairman | |
Omx Ventures LLC
 Omx Ventures LLC Investment ManagersFinance OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois. | Investment Managers | Private Equity Investor | |
Tentarix Biotherapeutics LP
 Tentarix Biotherapeutics LP BiotechnologyHealth Technology Tentarix Biotherapeutics LP operates as a biotechnology company. The company is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member | |
| CHINOOK THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member | |
| Tentarix Biotherapeutics, Inc. | Director/Board Member | ||
BlueRock Therapeutics LP
 BlueRock Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, BlueRock Therapeutics LP is a clinical stage cell therapy company focused on creating cellular medicines to reverse devastating diseases. The company is based in Cambridge, MA. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG as a cornerstone of its newly formed cell & gene therapy platform. The company's culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that they are all part of something bigger than themselves. BlueRock Therapeutics' lead clinical program, Bemdaneprocel (BRT-DA01), is in phase I clinical trials for Parkinson's disease. BlueRock Therapeutics was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG. Seth Ettenberg has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
Santa Ana Bio, Inc.
 Santa Ana Bio, Inc. BiotechnologyHealth Technology Santa Ana Bio, Inc. is a biotechnology company that specializes in precision immunology for autoimmune diseases. The company is based in Alameda, CA. The CEO of the company is Peter Emtage. | Biotechnology | Director/Board Member | |
Nested Therapeutics, Inc.
 Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nested Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company focuses on discovering and developing novel, targeted, small molecule precision medicine therapies for cancer patients. The company uses mutation clusters to identify druggable pockets and have a platform that utilizes insights from genomics, computational chemistry, proteomics, and AI. Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations to reach a broader group of patients. The company was founded by Arvin Dar and Klaus Hoeflich. The CEO is Darrin Miles. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
| United States | 29 |
| Canada | 14 |
| Switzerland | 4 |
| Finland | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 23 |
| Finance | 7 |
| Commercial Services | 7 |
| Consumer Services | 5 |
| Technology Services | 3 |
Operational
| Director/Board Member | 121 |
| Corporate Officer/Principal | 52 |
| Chairman | 24 |
| Independent Dir/Board Member | 17 |
| Private Equity Investor | 17 |
Most connected contacts
| Insiders | |
|---|---|
| Bradley Bolzon | 41 |
| Jerel Davis | 29 |
| José Baselga | 27 |
| Darlene Deptula-Hicks | 24 |
| Guido Magni | 23 |
| Stefan Mathias Larson | 14 |
| Gianni Gromo | 14 |
| Philip Vickers | 14 |
| Frédéric Sweeney | 14 |
| Rahul Ballal | 13 |
| Cédric Bisson | 12 |
| Francois Salmon | 10 |
| Lina Gugucheva | 9 |
| Angus M. Sinclair | 4 |
| Jordi Carrera Fabra | 3 |
- Stock Market
- Insiders
- Judit Anido Folgueira
- Company connections
